Manufacturers Life Insurance Company, The Annexon, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Annexon, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 93,806 shares of ANNX stock, worth $459,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,806
Previous 20,021
368.54%
Holding current value
$459,649
Previous $90,000
646.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ANNX
# of Institutions
138Shares Held
87.3MCall Options Held
2.54MPut Options Held
556K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.7MShares$42.6 Million9.43% of portfolio
-
Satter Management Co., L.P.7.41MShares$36.3 Million59.29% of portfolio
-
Bvf Inc San Francisco, CA7MShares$34.3 Million1.5% of portfolio
-
Redmile Group, LLC San Francisco, CA5.5MShares$27 Million1.56% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.16MShares$25.3 Million0.09% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $233M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...